| Tobin AA, Joseph BK, Albarwani S, Al-Kindi HN, Madden JA, Nemetz LT, Rusch NJ, Rhee SW. Loss of cerebrovascular Shaker-type K+ channels: a shared vasodilator defect of genetic and renal hypertensive rats. Am J Physiol – Heart Circ Physiol, 297(1): H293-H303, 2009. Rhee SW, Stimers JR, Wang W, Pang L. Vascular smooth muscle specific knockdown of non-cardiac form of L-type calcium channel by shRNA as a potential anti-hypertensive therapy. J Pharmacol Exp Ther, 329(2):775-82, 2009. Marsh JD, Telemaque S, Rhee SW, Stimers JR, Rusch NJ. Delivery of ion channel genes to treat cardiovascular diseases. Trans Am Clin Climatol Assoc, 119:171-183, 2008. Telemaque S, Sonkusare S, Grain T, Rhee SW, Stimers JR, Rusch NJ, Marsh JD. Design of mutant β subunits as decoy molecules to reduce the expression of functional Ca2+ channels in cardiac cells. J Pharmacol Exp Ther, 325 (1): 37-46, 2008. Jiang S, Rhee SW, Gleeson P, Storrie B. Capacity of the Golgi apparatus for cargo transport prior to complete assembly. Mol Biol Cell, 17 (9): 4105-17, 2006. Rhee SW, Starr T, Williams KF, Storrie B. The Steady-state distribution of glycosyltransferases between the Golgi apparatus and the endoplasmic reticulum is approximately 90:10. Traffic 6 (11): 978-990, 2005. |
